Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives

被引:55
作者
Nagarapu, Lingaiah [1 ]
Mateti, Jhansi [1 ]
Gaikwad, Hanmant K. [1 ]
Bantu, Rajashaker [1 ]
Rani, M. Sheeba [1 ]
Subhashini, N. J. Prameela [2 ]
机构
[1] Indian Inst Chem Technol CSIR, Organ Chem Div 2, Hyderabad 500607, Andhra Pradesh, India
[2] Osmania Univ, Dept Pharm, Univ Coll Technol, Hyderabad 500607, Andhra Pradesh, India
关键词
Nonsterodial anti-inflammatory drugs; Pyrazole carboxamide derivative; Ibuprofen; Celecoxib; SELECTIVE INHIBITORS; COX-2; INHIBITORS; CYCLOOXYGENASE-2; POTENT; IDENTIFICATION; INFLAMMATION; CELECOXIB; PYRAZOLES; MECHANISM; ANALOGS;
D O I
10.1016/j.bmcl.2011.05.105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives were synthesized and investigated their anti-inflammatory activities using carrageenan-induced rat paw edema model in vivo. All the synthesized compounds were found to be potent anti-inflammatory agents. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4138 / 4140
页数:3
相关论文
共 28 条
[1]   Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids [J].
Cottineau, B ;
Toto, P ;
Marot, C ;
Pipaud, A ;
Chenault, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) :2105-2108
[2]   The pyrrole moiety as a template for COX-1/COX-2 inhibitors [J].
Dannhardt, G ;
Kiefer, W ;
Krämer, G ;
Maehrlein, S ;
Nowe, U ;
Fiebich, B .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (05) :499-510
[3]   Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors [J].
de Gaetano, G ;
Donati, MB ;
Cerletti, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (05) :245-252
[4]   Adverse cardiovascular effects of the coxibs [J].
Dogné, JM ;
Supuran, CT ;
Pratico, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) :2251-2257
[5]   Treatment of rheumatoid arthritis. Evolution of concepts and strategies [J].
Dubost, JJ ;
Soubrier, M ;
Sauvezie, B .
REVUE DE MEDECINE INTERNE, 1999, 20 (02) :171-178
[6]   Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? [J].
Fiorucci, S ;
Meli, R ;
Bucci, M ;
Cirino, G .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (11) :1433-1438
[7]   Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2. [J].
FitzGerald, GA ;
Patrono, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :433-442
[8]   Coxibs and cardiovascular disease [J].
FitzGerald, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1709-1711
[9]   Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2 [J].
Fries, S ;
Grosser, T ;
Price, TS ;
Lawson, JA ;
Kapoor, S ;
Demarco, S ;
Pletcher, MT ;
Wiltshire, T ;
Fitzgerald, GA .
GASTROENTEROLOGY, 2006, 130 (01) :55-64
[10]   Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: Lead identification and SAR of 3-and 4-substituted derivatives [J].
Genin, MJ ;
Biles, C ;
Keiser, BJ ;
Poppe, SM ;
Swaney, SM ;
Tarpley, WG ;
Yagi, Y ;
Romero, DL .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (05) :1034-1040